Tretinoin
Also known as: All-trans retinoic acid · Retinoic acid
Topical Retinoid
COMPOUND CLASS
Topical retinoid (vitamin A derivative)
PRIMARY PATHWAY
Retinoic acid receptor (RAR) gene transcription
PRIMARY AREAS OF RESEARCH
Skin cell turnover, photoaging, acne biology, collagen signaling
RESEARCH STATUS
Decades of controlled human dermatology research
EVIDENCE LEVEL
Strong
OTHER NAMES
All-trans retinoic acid, Retinoic acid
What Is Tretinoin?
Tretinoin is the acid form of vitamin A. Unlike most topical ingredients that act on the skin's surface, tretinoin enters the cell and interacts with receptors located in the cell nucleus — the compartment that houses DNA.
That is what makes it unusual: it works at the level of gene expression, changing which instructions a skin cell reads. Because of this, tretinoin is one of the best-characterized compounds in all of dermatology research, supported by decades of controlled clinical studies.
- What it is
- A vitamin A derivative (a retinoid) that acts directly on genes inside skin cells.
- Category
- Dermatology and aesthetic research compound.
- Main system involved
- Retinoic acid receptors that control skin-cell turnover and collagen-related genes.
- Research interest
- Skin-cell turnover, acne biology, photoaging, and collagen remodeling.
- Research status
- One of the most extensively studied dermatology compounds, with decades of controlled human trials.
Why Are Researchers Interested?
Well-established evidence base
Effects on acne lesions and on photoaged skin have been demonstrated in numerous randomized controlled human trials. This is established science, not preliminary research.
Skin-cell turnover
It changes how quickly skin cells mature and shed, which is central to how pores become blocked.
Collagen remodeling
Studies have measured increased collagen production and reduced breakdown in sun-damaged skin.
A model for gene-level action
It serves as a textbook example of how a topical compound can act through nuclear receptors.
How It Works
Skin constantly renews itself: new cells form at the bottom layer, mature as they move up, and eventually flake off. In acne, that process goes awry and cells stick together inside pores, forming blockages.
Tretinoin enters cells and attaches to receptors that sit on DNA. Those receptors act like switches on a control panel, turning certain genes up or down. The result studied in trials is more organized cell turnover, fewer blocked pores, and — over months — increased production of collagen, the protein that gives skin its structure.
This is also why the well-documented early irritation, dryness, and peeling occur: the skin is adjusting to a faster renewal cycle.
Current Areas of Research
Acne biology
How blocked pores form and how retinoids change that process.
Photoaging
Effects on skin damaged by long-term sun exposure, including fine lines and texture.
Collagen and matrix
How collagen is produced and how its breakdown enzymes are regulated.
Barrier adaptation
Why irritation typically appears early and lessens over time.
Formulation science
How delivery vehicles and concentrations affect penetration and tolerability.
What Does the Evidence Actually Say?
Strong — topical tretinoin is one of the most extensively studied dermatology compounds, with long-running randomized human trials and regulatory approval for specific uses.
Side Effects & Safety Research
Documented in research
- Irritation, dryness, peeling, and redness are well documented, especially early in use.
- Increased sun sensitivity is a consistently reported finding.
Possible or theoretical
- Post-inflammatory pigment changes have been reported in some skin types.
What We Don't Know Yet
- Optimal long-term use patterns for cosmetic outcomes are still debated in the literature.
- Individual response varies widely, and the biological reasons are not fully explained.
- Comparative research between retinoid types is uneven.
- Tretinoin increases sun sensitivity, and its long-term interaction with sun exposure is an ongoing research consideration.
Frequently Asked Questions
Research References
- Kang S et al. Topical tretinoin therapy for photoaged skin. Archives of Dermatology, 1995.
- Leyden JJ. Retinoids and acne. Journal of the American Academy of Dermatology, 1998.
- Mukherjee S et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clinical Interventions in Aging, 2006.
Key Takeaway
Tretinoin is a vitamin A derivative that acts inside skin cells by switching genes on and off through nuclear receptors. Decades of controlled human research have established its effects on skin-cell turnover, acne lesion formation, and collagen remodeling in photoaged skin. It remains one of the most thoroughly documented compounds in dermatology, and research continues on formulation, tolerability, and long-term use.
Related Research
This information is provided for educational purposes only and summarizes current areas of scientific research. It is not medical advice, a treatment recommendation, or an instruction for personal use. Research findings may be preliminary, limited, or subject to change as new evidence becomes available.